Today, 85 years after its foundation, Corporación Farmacéutica Recalcine is the leading company in the pharmaceutical market in Chile. It is constantly developing biotechnology projects and clinical studies, supported by the main forming entities in Chile and abroad.
Corporación Farmacéutica Recalcine inaugurated in September 2006 the CFR Pharmafuturo Pharmaceutical Complex, with the purpose to become the first Latin American laboratory with a global presence and research of its own. CFR Pharmafuturo Pharmaceutical Complex was designed according to the GMP (Good Manufacturing Practice)
FTA with the EU would take effect in 2016 Ecuador
Ecuador and the EU predict that the free trade agreement that they have just signed in the Belgian capital, whose negotiation had ended in June, will take effect in 2016.
Copyright 1995 - 2014 Fish Info & Services Co.Ltd| All Rights Reserved. DISCLAIMER